The present invention refers to the use of an extract from chestnut shells (CSE), peeling waste of the chestnut, (fruit of the tree Castanea sativa Mill., European Chestnut), or fractions of said extract, with specific antiviral activity in the treatment and/or prevention of Herpesviridae, Retroviridae, and Coronaviridae infections.

The present invention refers to the use of an extract from chestnut shells (CSE), peeling waste of the chestnut, (fruit of the tree Castanea sativa Mill., European Chestnut), or fractions of said extract, with specific antiviral activity in the treatment and/or prevention of Herpesviridae, Retroviridae, and Coronaviridae infections.

A hair growth composition comprising Betula Pubescens Flower Bud, Populus Nigra Leaf Bud, at least one human hair, and RNA. The hair growth composition may also comprise Castanea Vesca and phosphorus. An effective amount of the hair growth composition can be administered sublingually, topically, by thin film patch, in tablet form, or a combination thereof.

A hair growth composition comprising Betula Pubescens Flower Bud, Populus Nigra Leaf Bud, at least one human hair, and RNA. The hair growth composition may also comprise Castanea Vesca and phosphorus. An effective amount of the hair growth composition can be administered sublingually, topically, by thin film patch, in tablet form, or a combination thereof.

A pharmaceutical composition comprising a tannin selected from 2-O-digalloyl-1,3,4,6-tetra-O-galloyl-β-D-glucose, 3-O-digalloyl-1,2,4,6-tetra-O-galloyl-β-D-glucose, 6-O-digalloyl-1,2,3,4-tetra-O-galloyl-β-D-glucose, 2,6-bis-O-digalloyl-1,3-di-O-galloyl-β-D-glucose, and 6-O-trigalloyl-1,2,3-tri-O-galloyl-β-D-glucose. The tannin may be derived from Quercus infectoria. The pharmaceutical composition is used in a method of treating cancer, particularly oral cancer.

A pharmaceutical composition comprising a tannin selected from 2-O-digalloyl-1,3,4,6-tetra-O-galloyl-β-D-glucose, 3-O-digalloyl-1,2,4,6-tetra-O-galloyl-β-D-glucose, 6-O-digalloyl-1,2,3,4-tetra-O-galloyl-β-D-glucose, 2,6-bis-O-digalloyl-1,3-di-O-galloyl-β-D-glucose, and 6-O-trigalloyl-1,2,3-tri-O-galloyl-β-D-glucose. The tannin may be derived from Quercus infectoria. The pharmaceutical composition is used in a method of treating cancer, particularly oral cancer.

The present invention relates to a skin topical composition having an antipruritic efficacy, comprising a combination of (A) birch sap and (B) betaine, and the skin topical composition does not comprise water added as a separate component. The skin topical composition is a pharmaceutical composition or a cosmetic composition.

The present invention relates to a skin topical composition having an antipruritic efficacy, comprising a combination of (A) birch sap and (B) betaine, and the skin topical composition does not comprise water added as a separate component. The skin topical composition is a pharmaceutical composition or a cosmetic composition.

A composition in a form suitable for topical administration has, in a cosmetically and/or pharmaceutically acceptable vehicle, at least one nettle (Urtica) extract, and can include a mixture of at least five plant extracts. Methods to manufacture such a composition are also disclosed. Such a composition is particularly useful for the prevention, treatment, relief and alleviation of the symptoms of haemorrhoidal disease as well as aiding healing, and soothing burns.

A composition in a form suitable for topical administration has, in a cosmetically and/or pharmaceutically acceptable vehicle, at least one nettle (Urtica) extract, and can include a mixture of at least five plant extracts. Methods to manufacture such a composition are also disclosed. Such a composition is particularly useful for the prevention, treatment, relief and alleviation of the symptoms of haemorrhoidal disease as well as aiding healing, and soothing burns.